{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T08:05:53Z","timestamp":1779696353917,"version":"3.53.1"},"reference-count":25,"publisher":"Scientific Scholar","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Amyloidosis is characterized by the extracellular deposition of fibrillar proteins, leading to tissue damage and dysfunction. Cardiac amyloidosis (CA) occurs when these fibrils accumulate in the heart\u2019s extracellular matrix, causing infiltrative cardiomyopathy, heart failure, and potentially death. Early diagnosis is imperative in accurate management. Transthyretin amyloidosis, either hereditary or age-related, is a common cause of CA, often presenting with left ventricular hypertrophy (LVH) and heart failure with preserved ejection fraction (HFpEF). This study investigates the utility of Tc-99 m Pyrophosphate (Tc-99 m PYP) imaging in diagnosing Transthyretin Amyloidosis ((ATTR)-CA) in patients with unexplained LVH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This prospective observational study, conducted between January 2023 and June 2024, involved 52 patients with clinical suspicion of CA and left ventricular wall thickness &gt;12 mm. Patients underwent Tc-99 m PYP scintigraphy, and the results were categorized as positive, negative, or equivocal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The study population\u2019s mean age was 64.6 years, with a male predominance (69%). Of the 52 patients, 9 (17.3%) had positive, 28 (53.8%) negative, and 15 (28.8%) equivocal Tc-99 m PYP scan results. Echocardiographic features, such as septal hypertrophy and granular speckled appearance, were significantly associated with positive scan findings. Comorbidities such as coronary artery disease and dyslipidemia were also common. Cardiac biomarkers NT-proBNP and troponin I showed elevated levels in patients with positive scan results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Tc-99 m PYP imaging is an effective noninvasive tool for diagnosing ATTR CA, particularly in patients with unexplained LVH. The presence of HFpEF, abnormal ECG, and restrictive features on echocardiography should prompt further investigation for CA. Early diagnosis allows for timely management, improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijnm.ijnm_156_24","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T02:00:36Z","timestamp":1751248836000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of ATTR Cardiac Amyloidosis in Patients with Left Ventricular Hypertrophy Using Tc-99m Pyrophosphate Scintigraphy"],"prefix":"10.25259","volume":"40","author":[{"given":"V M Vimala","family":"Priyadharshini","sequence":"first","affiliation":[{"name":"Department of Nuclear medicine, Apollo Hospitals, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indirani","family":"Muthukrishnan","sequence":"additional","affiliation":[{"name":"Department of Nuclear medicine, Apollo Hospitals, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Nuclear medicine, Apollo Hospitals, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"R1-20250701","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaccao.2021.09.004","article-title":"Aging, aortic stenosis, and transthyretin cardiac amyloidosis: A perfect cardiac storm?","volume":"3","author":"Bokhari","year":"2021","journal-title":"JACC CardioOncol"},{"key":"R2-20250701","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250701","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"key":"R4-20250701","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"R5-20250701","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4065\/mcp.2011.0296","article-title":"Current status of endomyocardial biopsy","volume":"86","author":"From","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"R6-20250701","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"R7-20250701","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1253\/circrep.CR-22-0110","article-title":"External validation of the kumamoto criteria in transthyretin amyloid cardiomyopathy screening \u2013 A retrospective cohort study","volume":"4","author":"Watanabe","year":"2022","journal-title":"Circ Rep"},{"key":"R8-20250701","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12947-021-00258-x","article-title":"Cardiac amyloidosis screening using a relative apical sparing pattern in patients with left ventricular hypertrophy","volume":"19","author":"Nakao","year":"2021","journal-title":"Cardiovasc Ultrasound"},{"key":"R9-20250701","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m) Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"R10-20250701","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/HFJI.HFJI_38_23","article-title":"Cardiac amyloidosis in South India: A tertiary care centre experience","volume":"1","author":"Jain","year":"2023","journal-title":"Heart Fail J India"},{"key":"R11-20250701","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J"},{"key":"R12-20250701","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/jpcs.jpcs_35_21","article-title":"Cardiac amyloidosis in India: A clinicopathological study","volume":"7","author":"Agarwal","year":"2021","journal-title":"J Pract Cardiovasc Sci"},{"key":"R13-20250701","first-page":"35","article-title":"Cardiac amyloidosis: A case series from India","volume":"67","author":"Raut","year":"2019","journal-title":"J Assoc Physicians India"},{"key":"R14-20250701","doi-asserted-by":"crossref","first-page":"838","DOI":"10.7326\/0003-4819-131-11-199912070-00007","article-title":"Systemic amyloidosis presenting with angina pectoris","volume":"131","author":"Al Suwaidi","year":"1999","journal-title":"Ann Intern Med"},{"key":"R15-20250701","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"key":"R16-20250701","first-page":"19","article-title":"The use of PYP scan for evaluation of ATTR cardiac amyloidosis at a tertiary medical centre","volume":"29","author":"Dower","year":"2022","journal-title":"Br J Cardiol"},{"key":"R17-20250701","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11604-021-01221-6","article-title":"Usefulness of quantitative (99m) Tc-pyrophosphate SPECT\/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis","volume":"40","author":"Ogasawara","year":"2022","journal-title":"Jpn J Radiol"},{"key":"R18-20250701","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"R19-20250701","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10554-022-02692-y","article-title":"Wild type cardiac amyloidosis: Is it time to order a nuclear technetium pyrophosphate SPECT imaging study?","volume":"39","author":"Shen","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"R20-20250701","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/medicina59020378","article-title":"Towards a diagnosis of cardiac amyloidosis: Single center experience with (99m) technetium pyrophosphate planar imaging and opportunities for standardization of diagnostic workflow","volume":"59","author":"Saleem","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"R21-20250701","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2020.02.030","article-title":"Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis","volume":"307","author":"Grigoratos","year":"2020","journal-title":"Int J Cardiol"},{"key":"R22-20250701","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"R23-20250701","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41408-019-0193-9","article-title":"Two types of amyloidosis presenting in a single patient: A case series","volume":"9","author":"Sidiqi","year":"2019","journal-title":"Blood Cancer J"},{"key":"R24-20250701","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaccas.2020.12.047","article-title":"Biopsy evidence of sequential transthyretin and immunoglobulin light-chain cardiac amyloidosis in the same patient","volume":"3","author":"Vergaro","year":"2021","journal-title":"JACC Case Rep"},{"key":"R25-20250701","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ehjci\/jeab095","article-title":"99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis","volume":"22","author":"Quarta","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Indian Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijnm.ijnm_156_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:38:28Z","timestamp":1779694708000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijnm.co.in\/assessment-of-attr-cardiac-amyloidosis-in-patients-with-left-ventricular-hypertrophy-using-tc-99m-pyrophosphate-scintigraphy\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijnm.ijnm_156_24","relation":{},"ISSN":["0972-3919","0974-0244"],"issn-type":[{"value":"0972-3919","type":"print"},{"value":"0974-0244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-12-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}